← Leaderboards
Laurence H Baker
University Of Michigan At Ann Arbor
$13,775,401
Attributed
$15,116,815
Total exposure
16
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $28.5M · FY2005–22$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$146,061,181 · 19
By mechanism
U10$128,728,908 · 5
U24$9,257,867 · 1
U54$7,406,716 · 2
P50$516,299 · 2
R21$140,800 · 1
M01$10,591 · 6
Top collaborators
- Edison Tak-Bun Liu5 shared
- David Tuveson5 shared
- Raphael E. Pollock4 shared
- Denise Reinke4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Eric R. Fearon$27,558,344
- Evan Todd Keller$23,141,123
- Steven Robinson$307,656
- Kyle C. Cuneo$715,235
- Scott Michael Schuetze$8,096,162
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsClinical ResearchInstitutionResearch PersonnelMalignant NeoplasmsBaseFundingSouthwest Oncology GroupProgramsSarcomaScienceCancer PreventionMemberResourcesPreventionMonitorResponseMinoritySafetyInnovationTechnologyOperative Surgical ProceduresStatistical CenterEthics
Grant awards (80)
Core A: Administrative Core$391,531
P50 · FY2022 · CA · contact PI
Developmental Research Program$124,768
P50 · FY2022 · CA · contact PI
Integrated Translational Cancer Science Center$404,730
U10 · FY2018 · CA
Integrated Translational Cancer Science Center$404,730
U10 · FY2017 · CA
SARC Sarcoma SPORE$2,161,999
U54 · FY2016 · CA · contact PI
Integrated Translational Cancer Science Center$397,716
U10 · FY2016 · CA
Clinical Trials$172,299
U54 · FY2016 · CA · contact PI
SARC Sarcoma SPORE$47,692
U54 · FY2016 · CA · contact PI
SARC Sarcoma SPORE$2,185,000
U54 · FY2015 · CA · contact PI
Integrated Translational Cancer Science Center$404,945
U10 · FY2015 · CA
Clinical Trials$159,320
U54 · FY2015 · CA · contact PI
SARC Sarcoma SPORE$2,162,001
U54 · FY2014 · CA
Integrated Translational Cancer Science Center$400,000
U10 · FY2014 · CA
Clinical Trials$169,736
U54 · FY2014 · CA · contact PI
Clinical Trials$167,606
U54 · FY2013 · CA · contact PI
Southwest Oncology Group Treatment Grant$8,923,498
U10 · FY2012 · CA · contact PI
Southwest Oncology Group Biorepository$1,125,491
U24 · FY2012 · CA · contact PI
Southwest Oncology Group Biorepository$697,714
U24 · FY2012 · CA · contact PI
Southwest Oncology Group Treatment Grant$196,749
U10 · FY2012 · CA · contact PI
Clinical Trials$181,063
U54 · FY2012 · CA · contact PI
Southwest Oncology Group Treatment Grant$8,893,886
U10 · FY2011 · CA · contact PI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs$2,878,195
U10 · FY2011 · CA · contact PI
Southwest Oncology Group Biorepository$1,000,950
U24 · FY2011 · CA · contact PI
Southwest Oncology Group Treatment Grant$665,444
U10 · FY2011 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$124,541
U24 · FY2011 · CA · contact PI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs$11,261,801
U10 · FY2010 · CA · contact PI
Southwest Oncology Group Treatment Grant$10,205,783
U10 · FY2010 · CA · contact PI
Southwest Oncology Group Treatment Grant$1,500,000
U10 · FY2010 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$1,125,491
U24 · FY2010 · CA · contact PI
Southwest Oncology Group Treatment Grant$410,460
U10 · FY2010 · CA · contact PI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs$10,708,109
U10 · FY2009 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$9,379,270
U10 · FY2009 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$1,093,403
U24 · FY2009 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$800,000
U10 · FY2009 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$779,775
U10 · FY2009 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$689,999
U10 · FY2009 · CA · contact PI
Southwest Oncology Group$267,015
U10 · FY2009 · CA · contact PI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs$17,268,272
U10 · FY2008 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$9,490,764
U10 · FY2008 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$1,061,839
U24 · FY2008 · CA · contact PI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs$464,405
U10 · FY2008 · CA · contact PI
Southwest Oncology Group$262,397
U10 · FY2008 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$628
U10 · FY2008 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$9,423,958
U10 · FY2007 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$999,441
U24 · FY2007 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$316,222
U10 · FY2007 · CA · contact PI
Southwest Oncology Group$255,214
U10 · FY2007 · CA · contact PI
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)$187,055
U10 · FY2007 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$159,600
U10 · FY2007 · CA · contact PI
Southwest Oncology Group$43,000
U10 · FY2007 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$10,752,585
U10 · FY2006 · CA · contact PI
Tumor Banking for the Southwest Oncology Group$1,001,598
U24 · FY2006 · CA · contact PI
Southwest Oncology Group$255,214
U10 · FY2006 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$236,910
U10 · FY2006 · CA · contact PI
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$8,026,280
U10 · FY2005 · CA
Tumor Banking for the Southwest Oncology Group$1,027,399
U24 · FY2005 · CA
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE$768,026
U10 · FY2005 · CA
Southwest Oncology Group$229,365
U10 · FY2005 · CA
IMATINIB MESYLATE IN PATIENTS WITH MALIGNANCY WITH SKELETAL METASTASIS$1,030
M01 · FY2005 · RR
SWOG - Foreign Accrual under UMi$0
U10 · FY2005 · CA
Southwest Oncology Group$178,101
U10 · FY2004 · CA
SOUTHWEST ONCOLOGY GROUP$52,627
U10 · FY2004 · CA
Imatinib Mesylate in Patients with Malignancy with Skeletal Metastasis$9,149
M01 · FY2004 · RR
SOUTHWEST ONCOLOGY GROUP$210,509
U10 · FY2003 · CA
SOUTHWEST ONCOLOGY GROUP$223,972
U10 · FY2002 · CA
Molecular Diagnosis of Sarcomas$140,800
R21 · FY2002 · CA
Phase II study of tailored dose docetaxel in metastatic breast cancer$0
M01 · FY2002 · RR
PILOT--CONNECTIVE TISSUE ONCOLOGY$0
P30 · FY2002 · CA
Phase II study of docetaxel &herceptin in metastatic breast cancer$0
M01 · FY2002 · RR
Phase II trial of ifosfamide, doxorubicin &G-CSF in soft tissue sarcomas$0
M01 · FY2002 · RR
CHEMOTHERAPY WITH DOXORUBICIN AND DOCETAXEL IN OPERABLE STAGE I BREAST CANCER$0
M01 · FY2002 · RR
SOUTHWEST ONCOLOGY GROUP$155,545
U10 · FY2001 · CA
PILOT--CONNECTIVE TISSUE ONCOLOGY$0
P30 · FY2001 · CA
SOUTHWEST ONCOLOGY GROUP$196,154
U10 · FY2000 · CA
NSABP BREAST CANCER PREVENTION TRIAL$206
M01 · FY2000 · RR
CHEMOTHERAPY WITH DOXORUBICIN AND DOCETAXEL IN OPERABLE STAGE I BREAST CANCER$206
M01 · FY2000 · RR
Phase II trial of ifosfamide, doxorubicin &G-CSF in soft tissue sarcomas$0
M01 · FY2000 · RR
CORE--CLINICAL TRIALS SUPPORT FACILITY$0
P30 · FY2000 · CA
Phase II study of docetaxel &herceptin in metastatic breast cancer$0
M01 · FY2000 · RR
Phase II study of tailored dose docetaxel in metastatic breast cancer$0
M01 · FY2000 · RR